Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangiosarcoma × Blood Specimen Collection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 96 Neoplasms 86 Colorectal Neoplasms 49 Lung Neoplasms 46 Prostatic Neoplasms 39 Carcinoma, Non-Small-Cell Lung 36 Melanoma 30 Pancreatic Neoplasms 28 Head and Neck Neoplasms 24 Neoplastic Cells, Circulating 23 Ovarian Neoplasms 22 Colonic Neoplasms 18 Uterine Cervical Neoplasms 17 Multiple Myeloma 17 Leukemia, Myeloid, Acute 17 Carcinoma, Hepatocellular 17 Neoplasm Metastasis 16 Glioma 16 Sarcoma 15 Hematologic Neoplasms 14 Esophageal Neoplasms 14 Glioblastoma 12 Endometrial Neoplasms 12 Myelodysplastic Syndromes 11 Lymphoma 11 Leukemia 11 Squamous Cell Carcinoma of Head and Neck 10 Carcinoma, Renal Cell 10 Brain Neoplasms 10 Liver Neoplasms 9

Interventions

Doxorubicin 15 Ifosfamide 9 pazopanib 6 Paclitaxel 6 pembrolizumab 4 Radiotherapy 4 Gemcitabine 4 Filgrastim 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Docetaxel 3 trebananib 2 cixutumumab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Watchful Waiting 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Conformal 2 Magnetic Resonance Spectroscopy 2 Imatinib Mesylate 2 Epirubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡